Garrison M W, Rotschafer J C, Crossley K B
Section of Clinical Pharmacology, St. Paul-Ramsey Medical Center, Minn 55101.
South Med J. 1989 Nov;82(11):1414-5. doi: 10.1097/00007611-198911000-00018.
We have reported two cases involving bacteremic patients who failed to respond adequately to the investigational agent daptomycin. Despite apparent sensitivity of the organisms, therapy was unsuccessful in both patients using the recommended dosage. The sponsor of daptomycin is currently reevaluating the recommendation and may be revising their dosage guidelines in the future.